MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
575.79
-3.75
-0.65%
Closed 19:25 05/14 EDT
OPEN
579.35
PREV CLOSE
579.54
HIGH
579.56
LOW
568.72
VOLUME
373.62K
TURNOVER
0
52 WEEK HIGH
609.35
52 WEEK LOW
272.12
MARKET CAP
24.44B
P/E (TTM)
21.25
1D
5D
1M
3M
1Y
5Y
1D
Insider Shake-Up at United Therapeutics Sparks Investor Buzz
TipRanks · 1d ago
United Therapeutics Enters Collaboration With Varda Space Industries To Explore The Use Of Microgravity To Develop Treatments For Rare Pulmonary Disease
Benzinga · 1d ago
United Therapeutics, Varda Space Industries team on use of microgravity
TipRanks · 1d ago
VARDA SPACE INDUSTRIES AND UNITED THERAPEUTICS COLLABORATE TO ADVANCE MICROGRAVITY-ENABLED TREATMENTS FOR RARE PULMONARY DISEASE
Reuters · 1d ago
Thiel-backed Varda to launch United Therapeutics’ drugs into orbit for microgravity testing: report
Seeking Alpha · 1d ago
United Therapeutics CFO presents at RBC Capital Markets Global Healthcare Conference
PUBT · 2d ago
United Therapeutics Phase 3 Lung Data Could Reshape Pulmonary Franchise Outlook
Simply Wall St · 3d ago
United Therapeutics CFO James Edgemond sells common shares worth $4.17 million
PUBT · 3d ago
More
About UTHR
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder product.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.